SCHEMBL27185086

SCHEMBL27185086

Cc1ncc(NC(=O)CNC2CCCC2)cc1NC(=O)c1cnn2cc(Br)sc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 5/20 0.35
▸ MGLL Q99685 1/20 0.34
▸ KDM4E B2RXH2 5/20 0.34
▸ GAA P10253 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ IRAK4 Q9NWZ3 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CHRM1 P11229 1/20 0.32
▸ PDGFRA P16234 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29759664 1.00 MEN1 (0.36) MEN1KMT2AALDH1A1MGLLKDM4E
SCHEMBL29759822 0.98 ALDH1A1 (0.34) MEN1KMT2AALDH1A1MGLLKDM4E
SCHEMBL27185269 0.98 ALDH1A1 (0.34) MEN1KMT2AALDH1A1MGLLKDM4E
SCHEMBL29759657 0.88 KDM1A (0.35) GAASMN1; SMN2IRAK4NPC1RAB9A
SCHEMBL24579053 0.88 KDM1A (0.35) GAASMN1; SMN2IRAK4NPC1RAB9A
SCHEMBL29759797 0.85 SMN1; SMN2 (0.41) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL24576846 0.85 SMN1; SMN2 (0.41) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL29759589 0.85 SMN1; SMN2 (0.41) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL29759738 0.84 GSK3B (0.40) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL30566501 0.84 GSK3B (0.40) MEN1KMT2AALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109917-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2024-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109917-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS PDGFRA, PDGFRB, ABL1 MEN1 3001/4885KMT2A 2278/4885ALDH1A1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback